Patents by Inventor Edward R. DAMIANO

Edward R. DAMIANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11633535
    Abstract: Certain embodiments provide multi-medicament or single medicament infusion systems for preventing the cross-channeling or improper delivery of medicaments. The system may include one or more of an infusion pump, medicament cartridges, cartridge connectors, a multi-channel fluid conduit, and an infusion set. The medicament cartridges may be sized and shaped differently such that the medicament reservoirs can only be inserted into the pump under selected configurations.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: April 25, 2023
    Assignee: BETA BIONICS, Inc.
    Inventors: Edward R. Damiano, David Matthew Henderson, Bryan Dale Knodel, Michael J. Rosinko
  • Patent number: 11610661
    Abstract: Systems and methods are disclosed herein for managing access to therapy controls of an ambulatory medicament pump that provides therapy to a subject using safe access levels associated with the therapy controls. The therapy change controls may enable modification of the corresponding therapy control parameters. The disclosed systems and methods can determine the eligibility of a subject receiving therapy from the ambulatory medicament pump or a user of the ambulatory medicament pump, for a safe access level and provide access to the corresponding therapy change controls. The ambulatory medicament pump may provide access to the therapy change controls upon receiving an access signal. In some cases, the ambulatory medicament pump may receive a time-based passcode and provide access to the therapy change controls upon receiving a matching passcode from the user.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: March 21, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Edward R. Damiano, Himanshu Patel, Firas H. El-Khatib, Robert James LeBourdais
  • Patent number: 11610662
    Abstract: Glucose control systems are disclosed. An ambulatory medicament pump that is configured to wirelessly transmit one or more of a plurality of glucose control parameters and glucose control therapy data to a second ambulatory medicament pump is disclosed. A control system for transferring historical pump data from a first ambulatory medicament pump to a second ambulatory medicament pump is also disclosed. The control system can receive the historical pump data from a first ambulatory medicament pump, determine that at least one of a plurality of pairing conditions is satisfied to connect the data interface to the second ambulatory medicament pump, transmit, via the data interface, a pairing signal to the second ambulatory medicament pump, and transmit at least one of the therapy data associated with the delivery of the glucose control therapy or the glucose control parameter.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: March 21, 2023
    Assignee: Beta Bionics, Inc
    Inventors: Edward R. Damiano, Firas H. El-Khatib, Himanshu Patel, Michael J. Rosinko, Robert James LeBourdais
  • Patent number: 11594314
    Abstract: Blood glucose control systems are disclosed. A blood glucose control system can receive a glucose level signal from a glucose sensor operatively coupled to a subject. The system can decode encoded data of the glucose level signal to obtain the glucose level of the subject and the indication of the glucose trend. The system can automatically calculate the dose control signal using a control algorithm configured to calculate regular correction boluses of glucose control agent in response to at least the glucose level of the subject. The system can select a dose control signal encoding profile from a plurality of dose control signal encoding profiles and, based on the dose control signal encoding profile, encode the dose control signal such that the pump controller can read the dose control signal. The system can transmit an encoded dose control signal to the pump controller.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: February 28, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Patent number: 11587664
    Abstract: Systems and methods are disclosed herein for providing a configuration code for customizing a glucose level control system for at least an initial period. The configuration code can be based on one or more dosing parameters from a tracked medicament therapy administered to a subject over a tracking period by the glucose level control system. The configuration code includes encoded dosing parameters including a correction dosing parameter based on at least some of the correction boluses of medicament administered during the tracking period, a food intake dosing parameter comprising an indication of a food intake bolus size of medicament based on one or more food intake boluses provided during the tracking period, and a basal dosing parameter based on at least some of the basal doses of medicament administered during the tracking period.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: February 21, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Firas H. El-Khatib, Himanshu Patel, Edward R. Damiano, Michael J. Rosinko
  • Patent number: 11571507
    Abstract: Certain embodiments provide multi-medicament or single medicament infusion systems for preventing the cross-channeling or improper delivery of medicaments. The system may include one or more of an infusion pump, medicament cartridges, cartridge connectors, a multi-channel fluid conduit, and an infusion set. The medicament cartridges may be sized and shaped differently such that the medicament reservoirs can only be inserted into the pump under selected configurations.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: February 7, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: Edward R. Damiano, David Matthew Henderson, Bryan Dale Knodel, Michael J. Rosinko, Justin P. Brown, Todd S. Ray, Mads Henrik Dall, David Chi-Wai Lim
  • Patent number: 11529466
    Abstract: Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: December 20, 2022
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Patent number: 11515027
    Abstract: Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.
    Type: Grant
    Filed: March 24, 2022
    Date of Patent: November 29, 2022
    Assignee: Beta Bionics, Inc.
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Publication number: 20220305202
    Abstract: Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.
    Type: Application
    Filed: March 29, 2022
    Publication date: September 29, 2022
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Publication number: 20220288309
    Abstract: Systems and methods presented herein relate to managing ambulatory medical device data access. A computing system of a networked computing environment can establish a direct end-to-end data connection to an ambulatory medical device via a wireless wide area network. A public key of the computing system may be transmitted to the ambulatory medical device permitting the ambulatory medical device to encrypt data to be transmitted to the computing system. The computing system may receive, via the direct end-to-end data connection, encrypted data from the ambulatory medical device, and upon decrypting the data can generate a therapy report based at least in part on the therapy data. This therapy report may include time-series therapy data relating to the therapy delivered by the ambulatory medical device over a particular time period. The computing system can restrict access to the therapy report to authorized users.
    Type: Application
    Filed: January 19, 2022
    Publication date: September 15, 2022
    Inventors: Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib, Michael J. Rosinko
  • Publication number: 20220277823
    Abstract: Glucose control systems are disclosed. An ambulatory medicament pump that is configured to wirelessly transmit one or more of a plurality of glucose control parameters and glucose control therapy data to a second ambulatory medicament pump is disclosed. A control system for transferring historical pump data from a first ambulatory medicament pump to a second ambulatory medicament pump is also disclosed. The control system can receive the historical pump data from a first ambulatory medicament pump, determine that at least one of a plurality of pairing conditions is satisfied to connect the data interface to the second ambulatory medicament pump, transmit, via the data interface, a pairing signal to the second ambulatory medicament pump, and transmit at least one of the therapy data associated with the delivery of the glucose control therapy or the glucose control parameter.
    Type: Application
    Filed: March 2, 2022
    Publication date: September 1, 2022
    Inventors: Edward R. Damiano, Firas H. El-Khatib, Himanshu Patel, Michael J. Rosinko, Robert James LeBourdais
  • Publication number: 20220257860
    Abstract: Glucose control systems are disclosed. An ambulatory medicament pump that is configured to wirelessly transmit one or more of a plurality of glucose control parameters and glucose control therapy data to a second ambulatory medicament pump is disclosed. A control system for transferring historical pump data from a first ambulatory medicament pump to a second ambulatory medicament pump is also disclosed. The control system can receive the historical pump data from a first ambulatory medicament pump, determine that at least one of a plurality of pairing conditions is satisfied to connect the data interface to the second ambulatory medicament pump, transmit, via the data interface, a pairing signal to the second ambulatory medicament pump, and transmit at least one of the therapy data associated with the delivery of the glucose control therapy or the glucose control parameter.
    Type: Application
    Filed: March 2, 2022
    Publication date: August 18, 2022
    Inventors: Edward R. Damiano, Firas H. El-Khatib, Himanshu Patel, Michael J. Rosinko, Robert James LeBourdais
  • Publication number: 20220222734
    Abstract: Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.
    Type: Application
    Filed: March 28, 2022
    Publication date: July 14, 2022
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Publication number: 20220223273
    Abstract: Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.
    Type: Application
    Filed: March 30, 2022
    Publication date: July 14, 2022
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Publication number: 20220218904
    Abstract: Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.
    Type: Application
    Filed: March 29, 2022
    Publication date: July 14, 2022
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Publication number: 20220223251
    Abstract: Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.
    Type: Application
    Filed: March 24, 2022
    Publication date: July 14, 2022
    Inventors: Michael J. Rosinko, Himanshu Patel, Edward R. Damiano, Firas H. El-Khatib
  • Patent number: D980857
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 14, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: David Chi-Wai Lim, Edward R. Damiano, Michael J. Rosinko, Mads Henrik Dall
  • Patent number: D980858
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 14, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: David Chi-Wai Lim, Edward R. Damiano, Michael J. Rosinko, Mads Henrik Dall
  • Patent number: D980859
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 14, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: David Chi-Wai Lim, Edward R. Damiano, Michael J. Rosinko, Mads Henrik Dall
  • Patent number: D981439
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 21, 2023
    Assignee: Beta Bionics, Inc.
    Inventors: David Chi-Wai Lim, Edward R. Damiano, Michael J. Rosinko, Mads Henrik Dall